Conference Coverage

Family history of psoriasis and PsA predicts disease phenotype


 

REPORTING FROM SPARTAN 2018

– Family history appeared to predict disease phenotypes for patients with psoriatic arthritis, according to the results of data presented at the 2018 Spondyloarthritis Treatment and Research Network annual meeting.

“Family history of psoriatic arthritis, compared with psoriasis, had increased risk for deformities and lower risk for plaque psoriasis,” Dilek Solmaz, MD, said.

AzriSuratmin/Thinkstock
The researchers from the University of Ottawa analyzed family history data from the Psoriatic Arthritis International Database for patients with psoriasis and/or psoriatic arthritis in an effort to evaluate the relationship between family history of psoriasis and/or psoriatic arthritis and disease phenotypes. They compared patients who had a family history of psoriasis with patients who had a family history of psoriatic arthritis and also compared each group with patients who did not have a family history of either disease.

Of the 1,393 patients analyzed, 444 had a family history of either psoriasis or psoriatic arthritis. Of those, 335 had only psoriasis in their family, while 74 patients had a family history of psoriatic arthritis.

The researchers included onset age, sex, nail involvement, enthesitis, presence of deformities, and plaque type.

In a univariate analysis, psoriasis was a risk factors for younger onset, female sex, nail disease, enthesitis, plaque type psoriasis, and not achieving minimal disease activity. Family history of psoriatic arthritis appeared to be a significant risk factor for deformations (odds ratio, 2.557) and a lower risk for plaque psoriasis (OR, 0.417).

In a multivariate analysis for family history, patients who had a family history of psoriatic arthritis had an increased risk for deformities, compared with patients with family history of psoriasis (OR, 2.143). Those patients also appeared to have a decreased risk for experiencing plaque psoriasis, compared with patients with a history psoriasis (OR, 0.324). All ORs were within the 95% confidence intervals.

“The differences between family history of psoriasis and psoriatic arthritis and their relationship between pustular and plaque phenotypes could point to different genetic backgrounds, as well as pathogenic mechanisms,” Dr. Solmaz said.

Recommended Reading

FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Dermatology
Study using U.K. data quantifies infection risk associated with psoriasis
MDedge Dermatology
Most PsA patients discontinue initial biologic within 12 months
MDedge Dermatology
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Dermatology
AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar
MDedge Dermatology
New PsA questionnaire fails to beat existing early screening methods
MDedge Dermatology
How to avoid severe diarrhea from apremilast
MDedge Dermatology
MACE risk similar across arthritis subtypes
MDedge Dermatology
Is PASI 100 the new benchmark in psoriasis?
MDedge Dermatology
Psoriasis duration reflects cardiovascular event risk
MDedge Dermatology